Primary |
Product Used For Unknown Indication |
41.3% |
Gout |
25.8% |
Behcet's Syndrome |
6.0% |
Hypertension |
3.5% |
Familial Mediterranean Fever |
2.4% |
Pneumonia |
2.2% |
Arthralgia |
1.9% |
Drug Use For Unknown Indication |
1.9% |
Overdose |
1.9% |
Pain |
1.9% |
Renal Transplant |
1.4% |
Asthma |
1.1% |
Back Pain |
1.1% |
Bipolar Disorder |
1.1% |
Constipation |
1.1% |
Depression |
1.1% |
Gastrointestinal Infection |
1.1% |
Gouty Arthritis |
1.1% |
Hypothyroidism |
1.1% |
Renal Failure Chronic |
1.1% |
|
Vomiting |
17.7% |
Toxicity To Various Agents |
15.9% |
Diarrhoea |
12.4% |
Renal Failure Acute |
9.7% |
Alanine Aminotransferase Increased |
3.5% |
International Normalised Ratio Increased |
3.5% |
Renal Failure |
3.5% |
Weight Decreased |
3.5% |
Aspartate Aminotransferase Increased |
2.7% |
Cardiac Arrest |
2.7% |
Drug Ineffective |
2.7% |
Drug Interaction |
2.7% |
Malaise |
2.7% |
Myopathy |
2.7% |
Neuromyopathy |
2.7% |
Rhabdomyolysis |
2.7% |
Urticaria |
2.7% |
White Blood Cell Count Increased |
2.7% |
Accidental Exposure |
1.8% |
Back Pain |
1.8% |
|
Secondary |
Product Used For Unknown Indication |
36.3% |
Gout |
13.5% |
Behcet's Syndrome |
13.3% |
Drug Use For Unknown Indication |
9.8% |
Hypertension |
4.2% |
Prophylaxis |
3.1% |
Diabetes Mellitus |
2.0% |
Pain |
1.9% |
Depression |
1.7% |
Seasonal Allergy |
1.7% |
Uveitis |
1.7% |
Completed Suicide |
1.7% |
Type 2 Diabetes Mellitus |
1.3% |
Atrial Fibrillation |
1.3% |
Arthralgia |
1.2% |
Myocardial Ischaemia |
1.2% |
Coronary Artery Disease |
1.1% |
Vasculitis |
1.1% |
Cardiac Failure |
1.0% |
Rheumatoid Arthritis |
0.9% |
|
Completed Suicide |
16.3% |
Renal Failure Acute |
10.3% |
Toxicity To Various Agents |
8.8% |
Pancreatitis Acute |
8.3% |
Vomiting |
8.3% |
Drug Interaction |
7.0% |
Rhabdomyolysis |
5.0% |
Thrombocytopenia |
4.8% |
Death |
4.5% |
Diarrhoea |
3.5% |
Oedema Peripheral |
3.0% |
Renal Failure |
2.8% |
Sepsis |
2.8% |
Weight Decreased |
2.8% |
Nausea |
2.3% |
Stevens-johnson Syndrome |
2.3% |
Leukopenia |
2.0% |
Metabolic Acidosis |
2.0% |
Suicide Attempt |
2.0% |
Cytolytic Hepatitis |
1.8% |
|
Concomitant |
Product Used For Unknown Indication |
29.3% |
Drug Use For Unknown Indication |
19.7% |
Gout |
9.3% |
Behcet's Syndrome |
7.4% |
Hypertension |
6.7% |
Prophylaxis |
4.0% |
Pain |
3.3% |
Rheumatoid Arthritis |
2.7% |
Diabetes Mellitus |
2.6% |
Atrial Fibrillation |
1.8% |
Multiple Myeloma |
1.6% |
Type 2 Diabetes Mellitus |
1.5% |
Depression |
1.4% |
Blood Cholesterol Increased |
1.4% |
Osteoporosis |
1.3% |
Arthritis |
1.2% |
Pulmonary Arterial Hypertension |
1.2% |
Insomnia |
1.2% |
Constipation |
1.1% |
Gastrooesophageal Reflux Disease |
1.1% |
|
Vomiting |
13.3% |
Weight Decreased |
11.8% |
Renal Failure Acute |
6.2% |
Gout |
6.1% |
Urinary Tract Infection |
5.6% |
Weight Increased |
4.9% |
Death |
4.8% |
Renal Failure |
4.7% |
Myocardial Infarction |
4.3% |
Thrombocytopenia |
4.1% |
Drug Ineffective |
3.9% |
Pneumonia |
3.7% |
Pain In Extremity |
3.5% |
Pruritus |
3.5% |
Rhabdomyolysis |
3.5% |
Pyrexia |
3.4% |
Rash |
3.4% |
Therapeutic Response Decreased |
3.4% |
Oedema Peripheral |
3.1% |
Sepsis |
3.1% |
|
Interacting |
Product Used For Unknown Indication |
48.5% |
Gout |
10.8% |
Coronary Artery Disease |
6.0% |
Drug Use For Unknown Indication |
3.8% |
Heart And Lung Transplant |
3.8% |
Bronchiolitis |
3.5% |
Hyperuricaemia |
3.1% |
Gouty Arthritis |
2.9% |
Heart Transplant |
2.1% |
Tooth Abscess |
2.1% |
Behcet's Syndrome |
1.8% |
Arthralgia |
1.7% |
Asthma |
1.7% |
Renal Transplant |
1.7% |
Pneumonia |
1.5% |
Hypertension |
1.3% |
Familial Mediterranean Fever |
1.1% |
Synovitis |
1.1% |
Atrial Fibrillation |
1.0% |
Dyslipidaemia |
0.8% |
|
Drug Interaction |
23.0% |
Toxicity To Various Agents |
15.8% |
Cardiac Arrest |
7.2% |
Renal Failure Acute |
6.6% |
Rhabdomyolysis |
5.3% |
Gastrointestinal Disorder |
4.6% |
Renal Failure |
4.6% |
Muscular Weakness |
3.3% |
Neutropenia |
3.3% |
Incorrect Dose Administered |
2.6% |
Multi-organ Failure |
2.6% |
Myopathy |
2.6% |
Pancytopenia |
2.6% |
Thrombocytopenia |
2.6% |
Weight Decreased |
2.6% |
White Blood Cell Disorder |
2.6% |
Agranulocytosis |
2.0% |
Cytolytic Hepatitis |
2.0% |
Fall |
2.0% |
Potentiating Drug Interaction |
2.0% |
|